Compare, Analyse Piramal Healthcare with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ACTAVIS (US) - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   ACTAVIS
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
ACTAVIS
Dec-18
PIRAMAL ENTERPRISES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,30313,866-   
Low Rs1,7979,301-   
Sales per share (Unadj.) Rs716.53,401.4-  
Earnings per share (Unadj.) Rs79.7-1,095.6-  
Cash flow per share (Unadj.) Rs107.9358.4-  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.514,029.1-  
Shares outstanding (eoy) m184.45332.60-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.63.4 104.5%   
Avg P/E ratio x32.0-10.6 -302.6%  
P/CF ratio (eoy) x23.632.3 73.1%  
Price / Book Value ratio x1.70.8 209.0%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,2923,852,785 12.2%   
No. of employees `0007.816.9 46.3%   
Total wages/salary Rs m22,5040-   
Avg. sales/employee Rs Th16,899.466,940.6 25.2%   
Avg. wages/employee Rs Th2,877.70-   
Avg. net profit/employee Rs Th1,879.9-21,561.6 -8.7%   
INCOME DATA
Net Sales Rs m132,1531,131,296 11.7%  
Other income Rs m3,12821,634 14.5%   
Total revenues Rs m135,2811,152,931 11.7%   
Gross profit Rs m66,29029,646 223.6%  
Depreciation Rs m5,202483,605 1.1%   
Interest Rs m44,09765,282 67.5%   
Profit before tax Rs m20,119-497,607 -4.0%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0126,910 0.0%   
Tax Rs m8,611-6,306 -136.6%   
Profit after tax Rs m14,701-364,391 -4.0%  
Gross profit margin %50.22.6 1,914.2%  
Effective tax rate %42.81.3 3,377.5%   
Net profit margin %11.1-32.2 -34.5%  
BALANCE SHEET DATA
Current assets Rs m122,742463,999 26.5%   
Current liabilities Rs m310,810410,468 75.7%   
Net working cap to sales %-142.34.7 -3,007.6%  
Current ratio x0.41.1 34.9%  
Inventory Days Days2320 117.8%  
Debtors Days Days3966 58.6%  
Net fixed assets Rs m116,904128,056 91.3%   
Share capital Rs m3690-   
"Free" reserves Rs m272,1610-   
Net worth Rs m272,5304,666,069 5.8%   
Long term debt Rs m270,1961,643,092 16.4%   
Total assets Rs m856,2617,294,128 11.7%  
Interest coverage x1.5-6.6 -22.0%   
Debt to equity ratio x1.00.4 281.5%  
Sales to assets ratio x0.20.2 99.5%   
Return on assets %6.9-4.1 -167.5%  
Return on equity %5.4-7.8 -69.1%  
Return on capital %12.4-4.8 -256.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,3120-   
CASH FLOW
From Operations Rs m-115,975404,170 -28.7%  
From Investments Rs m-8,265222,039 -3.7%  
From Financial Activity Rs m107,525-693,676 -15.5%  
Net Cashflow Rs m-16,650-67,131 24.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.66 Rs / USD

Compare PIRAMAL ENTERPRISES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare PIRAMAL ENTERPRISES With: CADILA HEALTHCARE  WYETH LTD  STERLING BIOTECH  ALEMBIC LTD  ELDER PHARMA  



Today's Market

How to Trade this Market Crash(Podcast)

India's #1 trader, Vijay Bhambwani, decodes the crash...and reveals hidden opportunities one could profit from.

Related Views On News

STRIDES PHARMA SCIENCE Plunges by 6%; BSE HEALTHCARE Index Down 3.1% (Market Updates)

Feb 28, 2020 | Updated on Feb 28, 2020

STRIDES PHARMA SCIENCE share price has plunged by 6% and its current market price is Rs 489. The BSE HEALTHCARE is down by 3.1%. The top gainers in the BSE HEALTHCARE Index are ERIS LIFESCIENCES LIMITED (up 3.4%) and PFIZER (up 1.7%). The top losers are STRIDES PHARMA SCIENCE (down 5.6%) and PIRAMAL ENTERPRISES (down 5.9%).

ALEMBIC PHARMA Plunges by 5%; BSE HEALTHCARE Index Down 2.0% (Market Updates)

Feb 28, 2020 | Updated on Feb 28, 2020

ALEMBIC PHARMA share price has plunged by 5% and its current market price is Rs 650. The BSE HEALTHCARE is down by 2.0%. The top gainers in the BSE HEALTHCARE Index are DR. LAL PATHLABS LTD (up 1.5%) and BLISS GVS PHARMA (up 0.6%). The top losers are ALEMBIC PHARMA (down 5.1%) and PIRAMAL ENTERPRISES (down 6.0%).

GRANULES INDIA Plunges by 5%; BSE HEALTHCARE Index Down 1.7% (Market Updates)

Feb 28, 2020 | Updated on Feb 28, 2020

GRANULES INDIA share price has plunged by 5% and its current market price is Rs 171. The BSE HEALTHCARE is down by 1.7%. The top gainers in the BSE HEALTHCARE Index are DR. LAL PATHLABS LTD (up 1.8%) and BLISS GVS PHARMA (up 0.4%). The top losers are GRANULES INDIA (down 5.3%) and PIRAMAL ENTERPRISES (down 5.7%).

SHILPA MEDICARE Plunges by 5%; BSE HEALTHCARE Index Down 1.7% (Market Updates)

Feb 28, 2020 | Updated on Feb 28, 2020

SHILPA MEDICARE share price has plunged by 5% and its current market price is Rs 442. The BSE HEALTHCARE is down by 1.7%. The top gainers in the BSE HEALTHCARE Index is BLISS GVS PHARMA (up 2.3%). The top losers is SHILPA MEDICARE (down 5.0%).

STAR CEMENT LTD Plunges by 6%; BSE 500 Index Down 2.4% (Market Updates)

Feb 28, 2020 | Updated on Feb 28, 2020

STAR CEMENT LTD share price has plunged by 6% and its current market price is Rs 84. The BSE 500 is down by 2.4%. The top gainers in the BSE 500 Index are HSIL LTD (up 5.6%) and OMAXE LTD (up 5.5%). The top losers are STAR CEMENT LTD (down 6.5%) and PIRAMAL ENTERPRISES (down 6.8%).

More Views on News

Most Popular

Multibaggers of the Next Decade (The 5 Minute Wrapup)

Feb 26, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade.

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks (Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

The Top 8 Trading Mistakes You Should Avoid (Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock (Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

Why I Expect the Coronavirus to Benefit My Latest Trade Recommendation (Fast Profits Daily)

Feb 19, 2020

This is how my latest trade recommendation will benefit from the Coronavirus scare.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

PIRAMAL ENTERPRISES SHARE PRICE


Feb 28, 2020 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

OTHER USEFUL LINKS

MARKET STATS